Summary
November 2007, Vol. 7, No. 11, Pages 1689-1703 , DOI 10.1517/14712598.7.11.1689

T-regulatory lymphocytes and chronic viral hepatitis

Simon M Rushbrook, Matthew Hoare & Graeme JM Alexander
University of Cambridge School of Clinical Medicine, Department of Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK +44 0 1223 586614; +44 0 1223 216111;
Author for correspondence



Both hepatitis B virus (HBV) and hepatitis C virus (HCV) can cause persistent viral infection in humans. Chronic infection is associated with a risk of cirrhosis and hepatocellular carcinoma. The cause of chronic infection is unknown. A large body of evidence suggests that a failure of the adaptive immune response is critical in the establishment of chronic infection. Recently a new group of T cells (T-regulatory cells), that express CD4+CD25+ and Foxp3, which can inhibit the cellular (CD4+/CD8+) immune response have been described. In this review the authors explore the thoughts regarding immune responses to HBV and HCV infections and the role of these T-regulatory cells in relation to the pathogenesis of chronic HBV and HCV infection and the potential for therapeutic intervention.

Full Text | PDF (593 KB) | PDF Plus (829 KB)

Forward Links to Citing Articles

Albert S. Reece. (2009) Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction. Addiction Biology 14:2, 214-226
Online publication date: 1-May-2009.
CrossRef
Esther Unitt, William Gelson, Susan E. Davies, Nicholas Coleman, Graeme J. M. Alexander. (2009) Minichromosome maintenance protein-2-positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation. Liver Transplantation 15:3, 306-312
Online publication date: 1-Apr-2009.
CrossRef
L. Alvarez-Lajonchere, N. H. Shoukry, B. Grá, Y. Amador-Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González-Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas-Carrera. (2009) Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 16:3, 156-167
Online publication date: 1-Apr-2009.
CrossRef
 

Prev. Article | Next Article
View/Print PDF (593 KB)
View PDF Plus (829 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
Simon M Rushbrook
Matthew Hoare
Graeme JM Alexander
Keywords:
FoxP3
hepatitis B
hepatitis C
regulatory T cells
viral hepatitis